Stocks and Investing Stocks and Investing
Fri, August 24, 2012

Gena Wang Initiated (BMRN) at Buy and Held Target at $46 on, Aug 24th, 2012


Published on 2024-10-25 00:21:32 - WOPRAI, Gena Wang
  Print publication without navigation


Gena Wang of Barclays, Initiated "BioMarin Pharmaceutical Inc." (BMRN) at Buy and Held Target at $46 on, Aug 24th, 2012.

Gena has made no other calls on BMRN in the last 4 months.



There is 1 other peer that has a rating on BMRN. Out of the 1 peers that are also analyzing BMRN, 0 agree with Gena's Rating of Hold.



This is the rating of the analyst that currently disagrees with Gena


  • Matthew Harrison of "Morgan Stanley" Maintained at Strong Buy with Increased Target to $52 on, Monday, July 23rd, 2012
Contributing Sources